Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.800 +0.380    +0.94%
03/02 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
WKN:  852009
  • Volume: 39,437
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 40.220 - 40.940
Pfizer 40.800 +0.380 +0.94%

PFE Balance Sheet

 
Featured here, the Balance Sheet for Pfizer Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
02/10
2022
03/07
2022
03/04
2021
31/12
Total Current Assets 70403 67466 54420 59693
Cash and Short Term Investments 36132 33312 - -
Cash - - - -
Cash & Equivalents 1298 1780 2470 1944
Short Term Investments 34825 31524 21427 29125
Total Receivables, Net 18620 17738 16342 15745
Accounts Receivables - Trade, Net 16076 15155 13225 11479
Total Inventory 9513 10454 9979 9059
Prepaid Expenses - - - -
Other Current Assets, Total 6138 5962 4197 3816
Total Assets 195350 195290 183841 181476
Property/Plant/Equipment, Total - Net 15441 15244 15109 17721
Property/Plant/Equipment, Total - Gross 30372 30213 30467 32795
Accumulated Depreciation, Total -14931 -14969 -15358 -15074
Goodwill, Net 49441 49891 50211 49208
Intangibles, Net 28151 29065 29816 25146
Long Term Investments 13888 18962 20737 21542
Note Receivable - Long Term 2544 2583 3117 4266
Other Long Term Assets, Total 10890 7660 7880 6566
Other Assets, Total 39001 37212 24934 27859
Total Current Liabilities 44314 47410 39268 42671
Accounts Payable 6267 6208 5506 5578
Payable/Accrued - - - -
Accrued Expenses 7261 6330 6547 7671
Notes Payable/Short Term Debt 1474 4739 394 605
Current Port. of LT Debt/Capital Leases 2566 1251 251 2085
Other Current liabilities, Total 26746 28882 26570 26732
Total Liabilities 102460 107821 101156 104013
Total Long Term Debt 32959 34500 35796 36195
Long Term Debt 32959 34500 35796 36195
Capital Lease Obligations - - - -
Deferred Income Tax 616 558 655 349
Minority Interest 259 261 261 262
Other Liabilities, Total 22838 16653 24782 23931
Total Equity 92890 87469 - -
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 476 476 476 473
Additional Paid-In Capital 91359 91183 90844 90591
Retained Earnings (Accumulated Deficit) 122967 116608 111193 103394
Treasury Stock - Common -113945 -113939 -113931 -111361
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -7967 -6859 -5897 -5634
Total Liabilities & Shareholders' Equity 195350 195290 183841 181476
Total Common Shares Outstanding 5612 5593 5591 5620
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
gregory post
gregory post Feb 03, 2023 7:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to 38$ in couple weeks
sayed Elsayed
sayed Elsayed Feb 01, 2023 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why that share can't get up inspite of good financial feedbacks? I 🙄
Ben Rudin
Ben Rudin Feb 01, 2023 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
propaganda
sayed Elsayed
sayed Elsayed Feb 01, 2023 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will it get up soon ?
Gábor Zsemberi
Gábor Zsemberi Feb 01, 2023 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that's what she said
Jay Clerk
Jay Clerk Feb 01, 2023 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not a chance the mainstream lamestream news has beencoveri g fir their death shot for far to long. Truth is leaking out everywhere on all social media sites regardless of thier covering for them . Its to late short this corrupt turd!
Romulus Son of Mars
Romulus7 Jan 31, 2023 12:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol. all those shots and can't beat revenue? money must have gone somewhere else 🤣
Invest Right
Invest Right Jan 31, 2023 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
clot shot
Ben Rudin
Ben Rudin Jan 31, 2023 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
corrupted company, search project veritage video
Ben Rudin
Ben Rudin Jan 31, 2023 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
veritias*
Zach Twist
Zach Twist Jan 31, 2023 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jay Clerk
Jay Clerk Jan 31, 2023 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow dump in pre market or get slammed interest rate damage coming tomorrow. Short it get em back
Jay Clerk
Jay Clerk Jan 26, 2023 11:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Project veritage video is going viral ,timber!
Jay Clerk
Jay Clerk Jan 26, 2023 8:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This turdsucker is easy money short short and short again
peter pan
peter pan Jan 25, 2023 5:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is the best short stock ever. I always like to short this worthless stock.
damian del
mudlog79 Jan 24, 2023 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short this trash scam to the ground
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email